Status:
COMPLETED
Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain
Lead Sponsor:
iX Biopharma Ltd.
Conditions:
Acute Pain
Bunion
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This study evaluates the safety and effectiveness of Wafermine™ for post-bunionectomy or post-abdominoplasty pain over a 24 hours period. For subjects undergoing bunionectomy, 2 out of 3 subjects will...
Eligibility Criteria
Inclusion
- Scheduled for a bunionectomy or mini abdominoplasty with no additional planned procedures.
- Good general health without clinically significant renal, hepatic, cardiac or respiratory disease, as determined by the Investigator.
Exclusion
- For those undergoing bunionectomy, other painful conditions involving the surgical foot.
- Positive lab values for Hepatitis B or C or HIV
Key Trial Info
Start Date :
August 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 17 2018
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT03246971
Start Date
August 24 2017
End Date
July 17 2018
Last Update
July 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lotus Clinical Research
Pasadena, California, United States, 91105